Focal and atypical neuropathies: plexopathy, entrapment and treatment-induced
Neuropathic pain · C8 · Reviewed by a board-certified pain physician on November 2, 2026
Bottom line
Severe acute limb pain followed by patchy weakness points to a plexopathy such as neuralgic or diabetic amyotrophy, not a disc; purely sensory anterolateral thigh pain is often meralgia paresthetica; and a rapid HbA1c fall can trigger painful neuropathy.
Key points
- Neuralgic amyotrophy: pain first, weakness later. Pain occurs in 96%, reaches its maximum within hours at a median of 9/10 and often wakes patients; weakness can lag the pain by two weeks or longer 1.
- Upper plexus and long thoracic nerve dominate. Upper plexus involvement, with or without a winged scapula, is most common; anterior interosseous involvement weakens pinch grip, and sensory loss is present in the majority 1.
- The diagnosis is clinical. Ancillary tests mainly exclude other causes, and a short course of high-dose oral corticosteroids is advised for patients seen early and still in pain 2.
- Diabetic amyotrophy follows weight loss. It occurs mostly in type 2 diabetes, often with fairly well controlled glucose and recent weight loss; severe thigh pain precedes spreading leg weakness 3.
- Rapid glucose correction can cause neuropathy. Treatment-induced neuropathy is acute neuropathic pain or autonomic dysfunction within 8 weeks of an HbA1c fall of at least 2 points over 3 months 4.
- Meralgia paresthetica is purely sensory. The lateral femoral cutaneous nerve (L2–L3) usually passes deep to the inguinal ligament medial to the anterior superior iliac spine, where belts compress it; a local anesthetic block diagnoses and treats it 5.
Watch for
Asymmetric leg weakness, atrophy and absent knee and ankle reflexes after severe thigh pain in diabetes are not one radiculopathy: needle EMG denervation cannot be localized to one root 3.
High-yield for the exam
- Treatment-induced neuropathy occurred in 10.9% of 954 neuropathy clinic referrals, and pain severity correlated with the HbA1c fall (R = 0.84) 4.
- An HbA1c fall of 2–3 points over 3 months carried a 20% risk of treatment-induced neuropathy; a fall of more than 4 points, over 80% 4.
- Most patients with diabetic amyotrophy improve, but recovery can take up to 2 years and few return to normal 3.
- In a randomized trial, ultrasound-guided lateral femoral cutaneous blocks with or without corticosteroid relieved meralgia similarly over 4 weeks 6.
- Ultrasound guidance is advised for lateral femoral cutaneous blocks because the nerve's course varies 6.
Numbers to know
| Item | Value |
|---|---|
| Neuralgic amyotrophy patients with pain | 96% 1 |
| Median peak pain in neuralgic amyotrophy | 9/10 1 |
| Treatment-induced neuropathy trigger | HbA1c fall of 2 or more points over 3 months 4 |
| Onset after the HbA1c fall | Within 8 weeks 4 |
| Diabetic amyotrophy recovery | Up to 2 years 3 |
| LFCN passing medial to the ASIS | 87% 5 |
Common traps
Practise this topic
4 more questions on this topic in the full question bank, with explanations and sources.
Sources
- van Alfen N. The neuralgic amyotrophy consultation. J Neurol, 2007. pmc.ncbi.nlm.nih.gov/articles/PMC2780663/
- Van Eijk JJ, et al. Neuralgic amyotrophy: an update on diagnosis, pathophysiology, and treatment. Muscle Nerve, 2016. pubmed.ncbi.nlm.nih.gov/26662794/
- Elafros MA, et al. Diabetic neuropathies. Continuum (Minneap Minn), 2023. pmc.ncbi.nlm.nih.gov/articles/PMC11088946/
- Gibbons CH, et al. Treatment-induced neuropathy of diabetes: an acute, iatrogenic complication of diabetes. Brain, 2015. pmc.ncbi.nlm.nih.gov/articles/PMC4285188/
- Kongkatong MM, et al. Emergency-physician performed, ultrasound-guided lateral femoral cutaneous nerve block for meralgia paresthetica: a report of two cases. Clin Pract Cases Emerg Med, 2023. pmc.ncbi.nlm.nih.gov/articles/PMC10247173/
- Palamar D, et al. Ultrasound-guided treatment of meralgia paresthetica: with or without corticosteroid? A double-blinded, randomized controlled study. Ann Indian Acad Neurol, 2023. pmc.ncbi.nlm.nih.gov/articles/PMC10081546/
Related topics
Independent study material for the ABA Pain Medicine exam, written and reviewed by a board-certified pain physician. Not medical advice; not affiliated with the American Board of Anesthesiology.